cuprizone has been researched along with Psychoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hikida, T; Kato, TA; Li, S; Ohgidani, M; Sakurai, K | 1 |
| Fukunari, A; Kajii, Y; Kano, S; Kondo, MA; Miwa, K; Ohzeki, H; Okada, K; Sakaue, M; Sawa, A; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H | 1 |
| Fukudome, D; Gallagher, M; Kamiya, A; Kondo, MA; Sawa, A; Smith, DR | 1 |
3 other study(ies) available for cuprizone and Psychoses
| Article | Year |
|---|---|
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice.
Topics: Animals; Cuprizone; Fingolimod Hydrochloride; Mice; Microglia; Neuroinflammatory Diseases; Psychotic Disorders | 2023 |
Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.
Topics: Animals; Astrocytes; Brain; Central Nervous System Stimulants; Chelating Agents; Copper; Cuprizone; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Hyperkinesis; Interleukin-6; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phencyclidine; Psychotic Disorders; Time Factors | 2013 |
Dimensional assessment of behavioral changes in the cuprizone short-term exposure model for psychosis.
Topics: Affect; Animals; Behavior, Animal; Cognition; Cuprizone; Disease Models, Animal; Executive Function; Male; Mice, Inbred C57BL; Psychotic Disorders; Social Behavior | 2016 |